iBio announced development of proprietary COVID-19 vaccine candidates
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 18, 2020, scientists from the University of Oxford’s Engineering Science Department and the Oxford Suzhou Centre…
On Mar. 18, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for the company’s…
On Mar. 18, 2020, Eli Lilly announced its scientists were partnering with the Indiana State Department of Health…
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
On Mar. 17, 2020, Quidel Corp. announced it had received Emergency Use Authorization (EUA) from the U.S. Food…
On Mar. 17, 2020, scientists reported the novel SARS-CoV-2 coronavirus that emerged in the city of Wuhan, China,…
On Mar. 16, 2020, Hologic announced the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization…
On Mar. 16, 2020, OpGen reported an update on the business of Curetis, the other party to the…
On Mar. 15, 2020, the National Institutes of Health (NIH) informed its staff that it had its first…
On Mar. 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
On Mar. 13, 2020, Roche announced the FDA has issued an Emergency Use Authorization for the cobasᆴ SARS-CoV-2…
On Mar. 13, 2020, Thermo Fisher Scientific announced the FDA has issued an emergency use authorization (EUA) for…
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
On Mar. 13, 2020, IDEXX Laboratories announced the company had seen no positive results in pets to date…
On Mar. 13, 2020, Luminex announced that four independent clinical laboratories had validated laboratory developed tests (LDTs) for…
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
On Mar. 12, 2020, Innovation Pharma announced research procedures that one of the 12 Regional Biocontainment Labs (RBLs)…
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
On Mar. 8, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…